A new trading day began on Tuesday, with CorMedix Inc (NASDAQ: CRMD) stock price down -4.28% from the previous day of trading, before settling in for the closing price of $9.82. CRMD’s price has ranged from $5.60 to $17.43 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 29.80% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 1006.19%. With a float of $69.35 million, this company’s outstanding shares have now reached $78.35 million.
CorMedix Inc (CRMD) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of CorMedix Inc is 11.97%, while institutional ownership is 50.85%. The most recent insider transaction that took place on Nov 24 ’25, was worth 727,927. Before that another transaction happened on Nov 14 ’25, when Company’s Director sold 30,000 for $11.42, making the entire transaction worth $342,600. This insider now owns 48,473 shares in total.
CorMedix Inc (CRMD) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.22 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1006.19% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Here are CorMedix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.46. Likewise, its price to free cash flow for the trailing twelve months is 9.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.05, a number that is poised to hit 0.84 in the next quarter and is forecasted to reach 2.54 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Let’s dig in a bit further. During the last 5-days, its volume was 2.81 million. That was better than the volume of 2.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.22%.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 3.47%, which indicates a significant decrease from 5.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.69 in the past 14 days, which was higher than the 0.64 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.98, while its 200-day Moving Average is $11.15. However, in the short run, CorMedix Inc’s stock first resistance to watch stands at $9.70. Second resistance stands at $10.00. The third major resistance level sits at $10.25. If the price goes on to break the first support level at $9.15, it is likely to go to the next support level at $8.90. Assuming the price breaks the second support level, the third support level stands at $8.60.
CorMedix Inc (NASDAQ: CRMD) Key Stats
With a market capitalization of 740.62 million, the company has a total of 78,789K Shares Outstanding. Currently, annual sales are 43,470 K while annual income is -17,930 K. The company’s previous quarter sales were 104,280 K while its latest quarter income was 108,560 K.
